1Analysis of older adults inclusion in clinical trials of FDA-approved new drugs in the United StatesDING Jing, XU Yang, YANG Yue, TIAN Li-juan449-4542Introduction to the WHO-listed authority frameworkLÜ Xu-feng, SU Yao, WANG Jia, XU Zhen-yu455-4603Research progress on clinical efficacy evaluation of traditional Chinese medicine treatment for chronic obstructive pulmonary disease based on causal learning model frameworkWEI Wei, WANG Bo-ran, WANG Jia-yun, ZHOU Xue-zhong461-4644Research progress on the mechanism of Huisheng Oral Liquid in the auxiliary treatment of non-small cell lung cancerZHENG Mao-dong, ZHANG Ben-chang, YAN Juan465-4695Use of Data Monitoring Committees in Clinical Trials,Guidance for Industry(draft guidance)——interpret the development and practice of Data Monitoring Committee from the updated FDA guidelinesZHENG Yu, DANG Hai-xia, LIU Jun, WANG Zhong, YU Ya-nan470-4756Analysis and consideration of classification for the causality assessment of adverse events in drug clinical trialsPEI Xiao-jing, LI Hai-yan, SHEN Yi-feng, LIU Min476-4807Study and analysis of the registration characteristics of clinical trials of poly ADP ribose polymerase inhibitors based on the ClinicalTrials databaseYIN Gui-sen, DONG Bai-hui, SU Jia-hang, LIU Fen, LI Jin-lan481-4878Standardization of the first batch of national reference standard of lysozymeLIU Li-sha, HE Dong-mei, LI Jing, DONG Xin, HE Lan-ying, ZHANG Dou-sheng, REN Li-ping, FAN Hui-hong488-4949Development of the first batch of saxagliptin monohydrate national control productZHAI Chen-fei, FENG Yu-fei, LUO Chen, LIU Qian, YANG Dong-sheng495-49910Research on chemical components of Danggui Beimu Kushen Pills based on UPLC-Q-TOF-MS/MS and in-depth analysis of feature-based molecular networkSUN Yan, CHENG Mei-ling, LI Zhi-xuan, WANG Rui, WANG Ying-li, QIN Xue-mei, LIU Rui500-51111In vitro and in vivo antibacterial activity of compound L007-0069 against Staphylococcus epidermidis and its antibacterial mechanismYANG Wen-yi, TU Xi-chen, HOU Zheng-li512-52012Comparison of dissolution profiles of carbamazepine tablets by paddle method and flow-through cell method and study on in vitro-in vivo correlationWU Bin, ZHU Xiao-yue, ZHU Xue-bin, ZHANG Shu-dong, HU Qin, WANG Lin, WU Zhao-wei521-52913Comparative assessment of potential risks associated with variable fill volumes in biopharmaceutical glass injection vialsLI Xiao-yu, QI Yan-fei, YUAN Shu-sheng, ZHAO Xia530-53714Clinical application expert consensus on Compound Phellodendron Liquid Coating for vaginitis and perineum wound infection(2025 edition)LI Jun, MEN Ao-xue, XUE Xiao-ou538-54515Efficacy and safety of baloxavir and oseltamivir for children with influenza:a Meta-analysisZENG Yuan-yuan, LI Wen-jing546-55116To investigate and analyze the signal of semaglutide adverse events based on the FAERS database in the United StatesLI Zhe, FU Yang552-560 